Clinical and Immunologic Efficacy of the Recombinant Adenovirus Type-5-Vectored (CanSino Bio) Vaccine in University Professors during the COVID-19 Delta Wave

Clinical and Immunologic Efficacy of the Recombinant Adenovirus Type-5-Vectored (CanSino Bio) Vaccine in University Professors during the COVID-19 Delta Wave

Information regarding the efficacy of the recombinant adenovirus type-5-vectored (CanSino Bio) vaccine against the COVID-19 disease in a real-life setting is limited. A retrospective cohort study was carried out in the teaching university community of the metropolitan area of Monterrey, Mexico, thro...

Full description

Bibliographic Details
Main Authors: Santos Guzmán-López, Armine Darwich-Salazar, Paola Bocanegra-Ibarias, Daniel Salas-Treviño, Samantha Flores-Treviño, Eduardo Pérez-Alba, Laura M. Nuzzolo-Shihadeh, Edelmiro Pérez-Rodríguez, Adrián Camacho-Ortiz
Format: Article
Language:English
Published: MDPI AG 2022-04-01
Series:Vaccines
Subjects:
COVID 19
vaccine
SARS-CoV-2
immunity
adenovirus vector vaccine
Online Access:https://www.mdpi.com/2076-393X/10/5/656

Internet

https://www.mdpi.com/2076-393X/10/5/656

Similar Items